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Rehabilitation of COPD patients: 
which training modality
E. Clini, S. Costi, M. Romagnoli, F. Florini
Introduction
In recent years evidence-based guidelines on
the risk factors, pathogenesis, diagnosis and treat-
ment of patients with Chronic Obstructive Pul-
monary Disease (COPD) have been developed [1].
Pharmacological therapy involves a substantial
part of resources in the long-term management of
these patients [2], which increases according to the
severity of the disease [3] and especially during
exacerbations [4].
Non pharmacological treatment has been gain-
ing more interest and has been evolving rapidly
over the past decade as an essential part of therapy
for COPD patients. They have a role both in the
early and advanced stages of COPD. Moreover,
most of these therapeutic options appear to be as-
sociated with improved quality of life and are cost-
effective [5].
Pulmonary Rehabilitation (PR) is the most im-
portant amongst non pharmacological treatments
for COPD patients. The aim of the present review
is to focus on the role of exercise training as the
most important part of the rehabilitation process
for these patients, as well as to address the ques-
tion on which training methods are the most bene-
ficial. So far, training the lower extremities during
PR has been recognised as the only effective activ-
ity according to scientific evidence [6].
Methods
This review is based on an evaluation of the
literature using a multimethod approach. This ap-
proach consisted of both a computerised MED-
LINE search from 1966 through June 2004 using
the following terms: pulmonary rehabilitation, ex-
ercise, lung disease/obstructive. Moreover, a fur-
ther search on the most relevant review articles has
been performed. Finally, consensus statements and
recommendations synthesised into general guide-
lines were also examined.
Therefore, this review is based mainly upon
data obtained from the major and relevant articles,
reviews and guidelines throughout the considered
research period.
Pulmonary rehabilitation: 
programs and efficacy
Pulmonary Rehabilitation (PR) is a multidis-
ciplinary intervention with high level of scientif-
ic evidence aiming to reduce disability and to im-
prove patient’s participation [7]. Indeed, PR cov-
ers a range of non-pulmonary problems that may
not be adequately addressed by medical therapy
in chronic respiratory diseases such COPD: these
problems include exercise de-conditioning, rela-
tive social isolation, altered mood states (espe-
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Non pharmacological therapy has been gaining more
interest and has been evolving rapidly over the last decade
as an essential part of therapy for COPD patients. Pul-
monary Rehabilitation (PR), the most important non
pharmacological treatment in patients with COPD, has a
primary goal: to achieve the highest possible level of indi-
vidual exercise tolerance, thus reducing the primary
and/or secondary health care utilisation. The aim of the
present review is to focus the role of exercise training in
these patients as well as to address the question on which
training methods are the most beneficial. We have there-
fore undertaken a MEDLINE-based search including the
terms: pulmonary rehabilitation, exercise, lung disease/ob-
structive.
Several strategies based on endurance or strength train-
ing are nowadays implemented during PR programmes in
order to maximise the benefits for each patient. The impaired
function of ambulation muscles causing breathlessness as one
of the more frequent symptoms in many COPD, suggests that
training the lower extremities is the most important goal to
achieve during pulmonary rehabilitation of these patients.
On the other hand, as muscle strength appears to be an inde-
pendent contributor to survival and utilisation of health care
resources, it seems largely justified also to include this fur-
ther modality in the PR program of these patients.
In conclusion, both modalities are effective and useful
for COPD patients. However, whether resistance training
should be administered to all COPD and which is the opti-
mal length of strength training still needs to be elucidated.
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cially depression), muscle wasting, and weight
loss. The components of PR may vary widely
from programme to program. However, a com-
prehensive PR program might include exercise
training, nutrition counselling, and education ses-
sions.
Baseline and outcome assessments of each
participant in a PR program should be made to
quantify individual gains and target areas for im-
provement. Assessments should include: detailed
measurements of respiratory function and muscle
strength (either peripheral and respiratory), exer-
cise capacity, breathlessness, impact of disease by
means of specific (e.g. St.George’s Respiratory
Questionnaire) [8] or generic (e.g. Medical Out-
comes Study Short Form-SF36) [9] question-
naires. The last three assessments should also be
recorded at the end of the PR program.
PR has been carefully evaluated in a large
number of clinical trials; the various benefits (im-
proving exercise capacity and quality of life and/or
reducing symptoms) were summarised in a very
recent systematic review [10]. It has been shown
that exercise capacity is a independent factor posi-
tively influencing hospital re-admission in COPD
[11]. Although PR per se has not been demonstrat-
ed to improve patients’ survival, patients who can
benefit the most from PR have shown the best sur-
vival over time [12].
COPD and disability
One of the elements in the vicious circle which
develops in patients with COPD is progressive
limitation in activity due to the progression of air-
way obstruction. Lack of exercise leads to physical
deconditioning which in turn decreases exercise
capacity.
It is commonly found that COPD patients feel
better after PR: they improve their exercise toler-
ance not as a result of improvement in lung func-
tion but simply because they improve their ability
to perform exercise. Psychological as well as phys-
iological changes are the basis for this improve-
ment.
For many years the focus on the factors limit-
ing exercise tolerance in respiratory patients has
been considered the pulmonary defects leading to
the ventilatory limitation to exercise. Many pa-
tients with COPD exhibit hyperinflation, the re-
sult of a combination of decreased lung elastic re-
coil and expiratory flow limitation. The problem
of hyperinflation is particularly acute during exer-
cise, when the combination of ventilatory limita-
tion and increased breathing frequency leads to a
progressive increase in dynamic hyperinflation
that rapidly curtails the patient’s ability to exer-
cise [13]. During incremental exercise tests a
large proportion of COPD patients experience de-
crease in inspiratory capacity (IC) [14]. However,
patients alter their activity levels because of their
perception of breathlessness (dyspnoea). Clinical
studies have suggested that there is a strong rela-
tionship between the degree of hyperinflation and
the severity of exercise-induced dyspnoea. Re-
cently, it has been found that a strong correlation
exists between the dynamic increase in IC and the
degree of exertional dyspnoea as assessed by the
Borg scale during a 6 minute walking distance
[15]. This suggests that the reduction in exercise
capacity observed in patients with COPD may be
a function of hyperinflation, but mediated via an
increase in exertional dyspnoea. So far, Wegner et
al. [16] has provided a numerical analysis of the
interaction between several measures of lung
function, exercise capacity and clinical ratings of
symptoms: they used a principal component
analysis to aggregate these outcomes into 3 inde-
pendent factors (lung function, exercise capacity
and clinical ratings), which together could explain
79% of the total variance. The fact that these 3
factors are independent demonstrates that mea-
sures of lung function cannot be used to reliably
predict exercise capacity or dyspnoea. Indeed,
COPD is a systemic disease with many extrapul-
monary effects. The impact of a given degree of
lung function impairment is highly dependent up-
on secondary physiological factors (muscle wast-
ing, malnutrition, hormonal changes, depression
and/or social isolation) [13].
In particular, recent studies have proved the
possible role played by the dysfunction of the
skeletal muscles of the limbs of COPD patients.
Several pathophysiological changes have been
documented as evidence of skeletal muscle dys-
function in these patients: low lactic acidosis
threshold, more rapid fall in intramuscular pH, re-
duction in muscles aerobic enzymes and in oxygen
uptake kinetics, reduction in muscle mass [17].
Despite this, the relative importance of each mech-
anism still remains to be defined. These findings,
taken as a whole, suggest that function of the am-
bulation muscles is abnormal in many COPD pa-
tients and that this dysfunction may be a contribu-
tor to exercise intolerance, as well.
The degree of physical activity also has a dis-
tinct influence on survival. So far, it has been
shown that a 2 year-survival of COPD patients un-
dergoing long-term oxygen therapy was higher
(70%) among those who had a normal activity
score as compared with the one (20%) of those
who were confined to bed [18]. More interesting-
ly, Gerardi et al. [19] studied the predictors of mor-
tality (up to 3-years) in 158 patients with severe
COPD following a comprehensive PR program:
they found that both high PaCO2, and low 12-
minute walking distance, FEV1, PaO2, BMI and
score on the CRD questionnaire were all associat-
ed with mortality. However, a low 12-minute
walking distance was the only significant predictor
of mortality (both total or due to a respiratory
cause) in a stepwise regression and multifactorial
analysis. Even if it is difficult to determine which
specific components of the rehabilitation program
were responsible for the better survival, there is no
doubt that improvement in physical performance
in these patients plays an important role (at least)
in improving their quality of life. Therefore, exer-
cise training is a crucial part of any rehabilitation
program.
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Training and rehabilitation
As a matter of fact, enhancing physical perfor-
mance is the most important therapeutic goal of
PR in patients with COPD.
Patient’s general physical activity can be mea-
sured by ergometry (either bicycle or treadmill to
assess the lower limb, and arm ergometer to assess
the upper limb performances) with the measure-
ment of a large number of physiological variables
(i.e. oxygen uptake, heart rate, or work rate) [20].
Submaximal intensity and duration are the modal-
ities of choice to assess the patient’s ability to ex-
ercise [7, 21]. A less complex approach is to use a
self-paced, timed walking test (6-minute walking
distance) [22] or the modified incremental walking
test (namely, a Shuttle test) [23].
Despite the fact that it is not possible to predict
the patient’s exercise capacity from the baseline
evaluation of lung function when in a stable con-
dition, recent data suggests that the baseline level
of exercise performance and arterial oxygenation
appears the most consistent correlating with the
change in walking ability in COPD patients recov-
ering from an acute exacerbation [24].
COPD patients at all stages of disease appear
to benefit from exercise training programs, im-
proving with respect to both exercise tolerance and
symptoms of dyspnea and fatigue [25]. Data sug-
gests that these benefits can remain over the end of
the program [26, 27], particularly if the patient
could maintain exercise activity at his/her home
[28]. To date, there is no consensus on whether re-
peated rehabilitation courses enable patients to
sustain (or improve) the benefits gained through-
out the initial course.
Training modality
Training of peripheral muscles can be applied
as endurance training or strength training. En-
durance training involves a larger muscle mass
working at moderate intensity for a longer period
of time; strength training, on the other hand, in-
volves a smaller muscle mass working at high in-
tensity for a short period of time. Both types of
training might significantly improve the patient’s
exercise performance, symptoms and the per-
ceived quality of life [21].
Due to the impaired function of the ambulation
muscles causing breathlessness as the more fre-
quent symptom in many COPD patients [29],
training the lower extremities appears to be the
most important goal to achieve during pulmonary
rehabilitation of these patients. Nonetheless, lower
extremities training is the only “scientific evidence
A” based component of comprehensive PR pro-
grams [6].
However, most of the COPD patients, due to
the systemic effect of their muscles dysfunction, al-
so experience an important loss of the upper limbs
functions which fairly correlates with reduction of
patient’s participation to daily living activities in-
volving arms. Therefore, training upper limbs,
might also be important in limiting the process of
patient’s deconditioning [30]. Upper limbs may be
specifically trained using arm ergometer and adopt-
ing modality similar to those used to train the low-
er muscle limbs. Several upper extremity training
programs were performed in COPD: in a ran-
domised control study significant improvements
were observed only in specific upper limbs perfor-
mance tests, but this result did not translate into a
significant improvement in tests simulating activi-
ties of daily living [31].
Finally, due to their compromission of the res-
piratory muscles contributing to dyspnea, exercise
limitation and hypercapnia [32, 33], COPD patients
might also benefit from training these group of
muscles. Positive results have been shown applying
not only inspiratory [34] but also expiratory muscle
training [35] to the most compromised COPD pa-
tients. No data is available on which method of res-
piratory muscle training should be practiced (resis-
tance loading, threshold loading, maximal inspira-
tory manouvres, or a combination of both); howev-
er, this training modality is not widely recommend-
ed in all patients undergoing comprehensive PR
programs [21].
Exercise training sessions range in frequency
and duration. The optimal length of the PR pro-
gram should be no less than 10-12 sessions (with
different distribution within consecutive weeks);
nevertheless, the longer the program, the higher
the gains obtained [10]. Table 1 resumes the
main characteristics of different exercise train-
ing, duration of sessions and length of the pro-
grams.
As a matter of fact, the question is not whether
exercise should be provided to patients, but which
kind of training modality is the most beneficial.
Endurance training
Endurance training is performed by progres-
sively increasing intensity (up to 70-90% of the
baseline achieved workload, mostly targeted by
means of the percentage of the maximal heart rate
or the percentage of the maximal oxygen uptake)
and duration (up to 20-45 consecutive minutes,
and repeated 3-5 times per week) of exercise de-
livered on a ergometry (cycloergometry or tread-
mill for the lower limbs and arm ergometry for the
upper limbs) [21].
Endurance is the ability to sustain physical ac-
tivity over time. This goal appears essential for
tasks with which COPD patients frequently strug-
gle such as walking, housework or climbing stairs.
A recent survey in the UK confirmed the impor-
tance of these activities to patients: respondents al-
so identified walking as the activity they would
most like to regain [36]. A common thought is that
the physical benefits of training are restricted to
the mode of exercise employed. Therefore, en-
durance appears as the most appropriate means of
improving the ability to sustain exercise. Indeed,
this allows patients to adopt a more active lifestyle,
not depending on old age, and linking this result
with other health outcomes (i.e. reduced risk of
subsequent hospitalisation) [11] in COPD.
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Overall, there is more scientific evidence to
support endurance training than other modalities.
Despite PR programs adopting a wide variety of
training regimes, a recent systematic review in-
cluding up to 1000 COPD underlined that around
90% of treated patients received endurance (aero-
bic) training [10]. Strength training has also been
shown to be as effective as endurance modality
[37, 38], however the number of patients included
in these studies was small. Moreover, the addition
of strength to endurance training does not system-
atically confer an additional improvement in the
whole body exercise performance or in the per-
ceived health-related quality of life [38, 39]. Final-
ly, the benefits of endurance training programs
may extend over one year [27, 40], while those ob-
tained by strength activities are no longer docu-
mented.
In debating the pros and cons of endurance
versus strength training one may really compare
different things. As a matter of fact the evidence
that endurance training may improve exercise per-
formance and health status in COPD patients is
convincing. On the other hand, given the high
prevalence of peripheral muscle dysfunction in
COPD patients, strength training per se also might
benefit these patients. However, convincing
demonstrations on the positive effect of the latter
training are less evident.
Strength (resistance) training
Strength training is performed by applying ad-
ditional weights to lower and upper limb move-
ment. By varying the additional load (lifting
weights that represent a 50-80% fraction of the
maximal weight that can be lifted just once by a
trained muscle) or the number of repetitions (three
series of 8-10 repetitions for three times a week),
the muscle adaptation in strength or endurance can
be modified [21]. Weight training can be done lift-
ing free weights, or on “multigym” systems.
Two major points may appear determinant to
encourage the use of strength (resistance) training
in COPD patients undergoing PR. Firstly, COPD is
now considered not only a disease of the respirato-
ry system but also a more complex disease with a
systemic impact, peripheral muscle weakness be-
coming a hallmark of the systemic impact of the
disease [41]. Secondly, quadriceps force has been
identified as a contributor to survival [42] and util-
isation of heath care resources [43] in these pa-
tients.
Moreover, it is also important to recognise that
one major principle for successful training is the
“overload principle”, so that muscular adaptations
will only appear if the muscle is sufficiently
stressed [44].
In healthy subjects muscular stress is obtained
when exercise is delivered at individual 70% VO2
peak [45]. Aerobic exercise capacity is often limit-
ed by ventilatory limitations in COPD patients.
The inability to increase pulmonary ventilation
above a level dictated by the lung function impair-
ment results in a premature termination of exer-
cise: however, it has been shown that at peak exer-
cise significant metabolic reserve is still present in
COPD patients [46]. Therefore, when large
amounts of peripheral muscles are stressed, each
individual muscle may be operating at an intensity
far from its potential maximum [46]. This evi-
dence suggests that training programs in COPD
patients should be adjusted to allow sufficient
muscular stress.
This option can be reached following two dif-
ferent strategies: 1) by increasing the peak ventila-
tory capacity (i.e. by giving optimal bronchodila-
tion, reducing the work of breathing or supporting
ventilation by means of supplying oxygen or non-
invasive mechanical ventilation) [47, 48, 49, 50];
Table 1. - Training modality: sites, types, intensity, duration of sessions and length of the programs
Sites Type Intensity Duration of the session Length of the program
Lower limbs Endurance • 70-90% of the • 20-45 minutes • 3-5 times/week 
max HR or VO2 up to 8 weeks
Strength • 50-80% fraction • 8-10 repetitions • 3 times/week 
of max weight lifted up to 3 series up to 8 weeks
Upper limbs Endurance • 70-90% of the max • 20-45 minutes • 3-5 times/week 
HR or VO2 up to 8 week
Strength • 50-80% fraction • 8-10 repetitions • 3 times/week
of max weight lifted up to 3 series up to 8 weeks
• Specific ADL • ???? • ????
(washing, dressing, ironing, etc.)
Respiratory Strength • 15 to 60% of MIP • 1 hour • 3-6 times/week
muscles or MEP up to 3 months
Legenda: HR= Heart Rate; VO2= Oxygen Uptake; ADL= Activity of Daily Living; MIP= Maximal Inspiratory Pressure; 
MIP= Maximal Expiratory Pressure.
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2) by reducing the amount of work performed (i.e.
by training small muscle groups on a resistance ba-
sis, thus resulting in significant effects also with a
modest number of repetitions) [37].
Resistance training is a very specific therapy
for muscle weakness and it can restore muscle
strength in COPD patients [39). Besides the well
documented effect mainly based on the improved
muscle oxidative capacity [51], strength training
might result, especially in the older patients, in ad-
ditional benefits like improved bone mineral den-
sity [52], prevention in fall [53] and in whole body
endurance [54].
Despite this, the combination of resistance and
endurance training is the more common adopted
feature to train COPD patients, strength training
per se may produce overall improvements similar
to those obtained with endurance training alone
[37, 38].
Conclusions
Pulmonary Rehabillitation is widely consid-
ered as the most important non pharmacological
treatment for COPD patients. Charges of PR main-
ly depend on program complexity and on the num-
ber of health professionals [55] involved. In recent
years, it has been claimed that charges might enter
in a more sophisticated cost-benefit analysis. A
RCT from the UK provided evidence that an in-
tensive (6-week, 18-visit) multidisciplinary reha-
bilitation program was effective in decreasing use
of health services [56]. Indeed, the rehabilitation
group had more primary-care consultations at the
general practitioner’s than the control group, but
fewer primary-care home visits. As a matter of
fact, a better management of this disease may pos-
itively impact on costs related to hospitalisation
and drug usage under exacerbation [57]. In partic-
ular, improving the patient’s exercise tolerance is
the most important goal to achieve with this treat-
ment, thus reducing the primary and/or the sec-
ondary health care utilisation.
Training should always be proposed to COPD
patients irrespective of their age or functional sta-
tus. Despite the fact that only training the lower
limbs has the maximal level of scientific evidence,
several data also shows that training the upper
limbs or the respiratory muscles might result in
specific benefits to these patients.
Several strategies based on endurance or
strength training are nowadays implemented in or-
der to maximise the patient’s benefits [58, 59]. In
COPD patients combination programs resulted in
significant improvements of the overall skeletal
muscle performance [37, 38]: however, strength
training seems not to confer additional benefit to
the whole body exercise capacity.
Nonetheless, the impaired function of the am-
bulation muscles causing breathlessness as the
more frequent symptom in many COPD, suggests
that training the lower extremities is the most im-
portant goal to achieve during PR of these patients.
On the other hand, as muscle strength appears to
be an independent contributor to survival and util-
isation of health care resources [42], it seems
largely justified also to include this modality in the
PR program of these patients.
In COPD, rather than arguing the primacy of
one method over another, the most important goal
should be to tailor the patient’s training to meet
his/her specific performance deficits. Therefore,
not only endurance but also strength training, giv-
en the high prevalence of muscle weakness in
COPD patients, should be implemented.
However, some more questions deserve further
studies. In particular, could we administer resis-
tance training to all COPD? Is the optimal length
of resistance training similar to that usually per-
formed for endurance training? To date, literature
is still inconclusive regarding these aspects. Trying
to interpret the evidence, we could conclude that
resistance training can be used as a strategy in
those patients with a severe ventilatory limitation;
this approach to strengthen the skeletal muscles
may serve as an additional modality to further im-
prove the benefits of a PR program.
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